Li, Yonghe
Mayo Clinic in Florida
12 papers on CoChatORCID 0000-0003-3489-6362
Most cited papers
- Verified
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
Jia, L., Piña-Crespo, J., & Li, Y. (2019) · Molecular Brain
Alzheimer's disease research and treatmentsWnt/β-catenin signaling in development and cancer
Cited by 288
- Verified
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Lu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE
Wnt/β-catenin signaling in development and cancerHedgehog Signaling Pathway Studies
Cited by 230
- Verified
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Arend, R. C., Londoño-Joshi, A. I., Samant, R. S., Li, Y., Conner, M., Hidalgo, B., Alvarez, R. D., Landen, C. N., Straughn, J. M., & Buchsbaum, D. J. (2014) · Gynecologic Oncology
Wnt/β-catenin signaling in development and cancerCancer Cells and Metastasis
Cited by 161
- Verified
LRP1 is a neuronal receptor for α-synuclein uptake and spread
Chen, K., Martens, Y. A., Meneses, A., Ryu, D. H., Lu, W., Raulin, A. C., Li, F., Zhao, J., Chen, Y., Jin, Y., et al. (2022) · Molecular Neurodegeneration
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 115
- Verified
APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Liu, C.-C., Murray, M. E., Li, X., Zhao, N., Wang, N., Heckman, M. G., Shue, F., Martens, Y., Li, Y., Raulin, A.-C., et al. (2021) · Science Translational Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 108
- Verified
Effect of Niclosamide on Basal-like Breast Cancers
Londoño-Joshi, A. I., Arend, R. C., Aristizabal, L., Lu, W., Samant, R. S., Metge, B. J., Hidalgo, B., Grizzle, W. E., Conner, M., Forero-Torres, A., et al. (2014) · Molecular Cancer Therapeutics
Wnt/β-catenin signaling in development and cancerCancer Cells and Metastasis
Cited by 97
- Verified
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
Li, Y., Macyczko, J. R., Liu, C.-C., & Bu, G. (2022) · Neurobiology of Aging
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 61
- Verified
Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding
Li, Y., Chen, J., Lu, W., McCormick, L. M., Wang, J., & Bu, G. (2005) · Journal of Cell Science
Wnt/β-catenin signaling in development and cancerCholesterol and Lipid Metabolism
Cited by 53
- Verified
Sex specific molecular networks and key drivers of Alzheimer’s disease
Guo, L., Cao, J., Hou, J., Li, Y., Huang, M., Zhu, L., Zhang, L., Lee, Y., Duarte, M. L., Zhou, X., et al. (2023) · Molecular Neurodegeneration
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 49
- Verified
APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids
Zhao, J., Ikezu, T. C., Lu, W., Macyczko, J. R., Li, Y., Lewis-Tuffin, L. J., Martens, Y. A., Ren, Y., Zhu, Y., Asmann, Y. W., et al. (2023) · Stem Cell Research & Therapy
Alzheimer's disease research and treatmentsPluripotent Stem Cells Research
Cited by 25
- Verified
Modulation of LRP6‐mediated Wnt signaling by molecular chaperone Mesd
Li, Y., Lu, W., He, X., & Bu, G. (2006) · FEBS Letters
Wnt/β-catenin signaling in development and cancerHeat shock proteins research
Cited by 25
- Verified
CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease
Lu, W., Kawatani, K., Ren, Y., Nambara, T., Jia, L., Jeevaratnam, S., Lee, E., Martinez, P. R., Izhar, T., Wang, N., et al. (2026) · Alzheimer's Research & Therapy
Alzheimer's disease research and treatmentsHistone Deacetylase Inhibitors Research
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free